AIM
LMAT icon

Acrospire Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Acrospire Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,177
Closed -$68K – 796
2017
Q2 		$68K Sell
2,177
-200
-8% -$5.78K 0.06% 556
2017
Q1 		$59K Sell
2,377
-3,490
-59% -$81.9K 0.05% 789
2016
Q4 		$149K Buy
5,867
+698
+14% +$15.5K 0.06% 610
2016
Q3 		$103K Sell
5,169
-5,800
-53% -$101K 0.07% 528
2016
Q2 		$157K Sell
10,969
-6,094
-36% -$93.2K 0.12% 176
2016
Q1 		$265K Buy
+17,063
New +$245K 0.18% 102

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acrospire Investment Management's LMAT Position: Q3 2017 in Review

Acrospire Investment Management sold out of LeMaitre Vascular (LMAT) in Q3 2017, closing a stake of 2,177 shares — an estimated $68K sold.

Acrospire Investment Management first reported a position in LMAT in Q1 2016 and held it in 6 quarters. The position peaked at $265K in Q1 2016. 148 funds tracked by Wall St. Rank hold LMAT as of Q3 2017.

  • Acrospire Investment Management reported no remaining LeMaitre Vascular position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,177 LeMaitre Vascular shares in Q3 2017, an estimated $68K.
  • Acrospire Investment Management first reported a position in LeMaitre Vascular in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's LeMaitre Vascular position peaked at $265K in Q1 2016.
  • 148 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.